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Letter to the Editor 
First report of an mcr-1 -harboring Salmonella enterica 
subsp. enterica serotype 4,5,12:i:- strain isolated from 
blood of a patient in Switzerland 
Sir, 
In the past, colistin use has been mostly limited to veterinary 
medicine owing to its rather severe side effects, but given the 
increase in multidrug-resistant Gram-negative bacterial infections, 
the World Health Organization (WHO) recently re-labelled colistin 
as a ‘critically important antibiotic’. The ﬁrst description of the 
plasmid-borne mobilizable colistin resistance gene mcr-1 in 2015 
[1] caused great concern, as the ease of potential spread on a con- 
jugative plasmid encoding resistance to polymyxins might change 
the resistance situation to colistin drastically. In line with this, 
mcr-1 -mediated colistin resistance in Enterobacteriaceae, including 
Salmonella enterica , has since been reported from a wide range of 
geographical locations [2] . Here we report the ﬁrst case of mcr-1- 
harboring S. enterica in Switzerland. 
Salmonella enterica subsp. enterica serotype 4,5,12:i:- strain 
N17-0346 was isolated in 2017 from the blood of a 77- 
year-old male patient in Switzerland with no known travel 
history. The serotype was determined by the Swiss National 
Reference Centre for Enteropathogenic Bacteria and Listeria 
(NENT) according to the White–Kauffmann–Le Minor scheme. 
The strain was subjected to antimicrobial susceptibility test- 
ing to 16 antimicrobial agents by the disk diffusion method 
according to Clinical and Laboratory Standards Institute (CLSI) 
protocols and the results were evaluated according to CLSI 
criteria [3] . Determination of the colistin minimum inhibitory 
concentration (MIC) was performed by the broth microdilu- 
tion method according to the European Committee on An- 
timicrobial Susceptibility Testing (EUCAST) ( http://www.eucast. 
org ). Strain N17-0346 was phenotypically resistant to colistin 
(MIC = 4 mg/L), ampicillin and streptomycin but was suscepti- 
ble to amoxicillin/clavulanic acid, cefazolin, cefotaxime, cefepime, 
gentamicin, kanamycin, nalidixic acid, ciproﬂoxacin, trimetho- 
prim/sulfamethoxazole, azithromycin, fosfomycin, nitrofurantoin, 
tetracycline and chloramphenicol. 
Strain N17-0346 was sequenced using a MiSeq plat- 
form (Illumina Inc., San Diego, CA) and a Nextera XT Li- 
brary Kit (Illumina Inc.) utilising either 500 or 600 cy- 
cles of paired-end reads. De novo assembly using CLC Ge- 
nomics Workbench v.9.0 (CLC Bio, Aarhus, Denmark) re- 
sulted in a genome size of 4 981 418 bp with 95 contigs 
and a GC content of 52.1%. The genome was annotated using 
the Rapid Annotation using Subsystem Technology (RAST) anno- 
tation server and 5061 coding sequences (CDS) were identiﬁed. 
In silico seven-gene multilocus sequence typing (MLST) using 
seq2mlst v.1.0.1 (https://github.com/lmc297/seq2mlst) identi- 
ﬁed strain N17-0346 as ST34. Core-genome MLST using the 
command-line implementation of SISTR v.1.0.2 classiﬁed it as 
ST3833327333. Genome-wide detection of antimicrobial resis- 
tance (AMR) genes using the method described and validated for 
Salmonella Typhimurium by Carroll et al. [4] and implemented 
in BTyper v.2.2.0 (https://github.com/lmc297/BTyper) in conjunc- 
tion with the ARG-ANNOT AMR gene database, PlasmidFinder 
and PlasFlow v.1.0 produced the following hits: mcr-1 encoded 
on an IncX4 plasmid (pN17-0346) with no further AMR genes 
on the same contig; strA / strB (conferring streptomycin resis- 
tance) and sulII (encoding sulfonamide resistance) located on 
an IncQ1 plasmid; bla TEM-30 (coding for an inhibitor-resistant 
β-lactamase) on a contig classiﬁed as belonging to a plasmid; 
and aac(6 ʹ)-Iaa (aminoglycoside acetyltransferase) encoded on the 
chromosome. 
To generate a closed plasmid sequence of the mcr-1 -coding 
sequence pN17-0346, the plasmid was sequenced using a Nex- 
tera DNA Flex Sample Preparation Kit on an Illumina MiniSeq Se- 
quencer with 150-bp paired-end reads, yielding the closed 34 092- 
bp plasmid sequence with a per base coverage of > 50 × for all 
bases. RAST annotation determined 51 CDS and a partial insertion 
sequence (IS) element. The mcr-1 -coding sequence was located di- 
rectly upstream of an open reading frame encoding a hypothetical 
protein with similarities to a PAP2 superfamily protein that is fre- 
quently seen in association with mcr-1 [5] . A single copy of an in- 
complete version of IS Apl1 was located downstream of the mcr-1 
cassette, but no IS Apl1 element was identiﬁed upstream of it. 
Conjugal transfer of the mcr-1 -harboring IncX4 plasmid from 
donor strain N17-0346 to the recipient Escherichia coli HK225 
(streptomycin- and rifampicin-resistant) was tested at 25 °C and 
37 °C in liquid medium as well as on solid agar plates. Transconju- 
gants carrying the mcr-1 gene as conﬁrmed by PCR were found in 
all of these experiments, with a conjugation eﬃciency of 2.2 ×10 –4 
per donor cell on solid agar at 37 °C. The parent E. coli HK225 had a 
colistin MIC of 1 mg/L; after conjugation of the IncX4 plasmid, the 
MIC increased to 4 mg/L. To our knowledge, this is the ﬁrst report 
of a Salmonella strain carrying an mcr-1 colistin resistance gene in 
Switzerland. 
The full sequence of strain N17-0346 has been deposited in 
GenBank under the accession no. QEAL0 0 0 0 0 0 0 0 and the se- 
quence of the mcr-1 -harboring plasmid pN17-0346 under accession 
no. NZ _ CP031291.1 
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